- Home
- MGIC vs KTTA Comparison
MGIC vs KTTA Comparison
Compare MGIC & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGIC
- KTTA
- Stock Information
- Founded
- MGIC 1983
- KTTA 2020
- Country
- MGIC Israel
- KTTA United States
- Employees
- MGIC N/A
- KTTA 4
- Industry
- MGIC Computer Software: Prepackaged Software
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- MGIC Technology
- KTTA Health Care
- Exchange
- MGIC Nasdaq
- KTTA Nasdaq
- Market Cap
- MGIC 990.3M
- KTTA 5.5M
- IPO Year
- MGIC 1991
- KTTA 2021
- Fundamental
- Price
- MGIC $19.39
- KTTA $0.72
- Analyst Decision
- MGIC Buy
- KTTA
- Analyst Count
- MGIC 2
- KTTA 0
- Target Price
- MGIC $18.00
- KTTA N/A
- AVG Volume (30 Days)
- MGIC 41.9K
- KTTA 201.4K
- Earning Date
- MGIC 11-17-2025
- KTTA 11-12-2025
- Dividend Yield
- MGIC 2.91%
- KTTA N/A
- EPS Growth
- MGIC 16.93
- KTTA N/A
- EPS
- MGIC 0.78
- KTTA N/A
- Revenue
- MGIC $584,528,000.00
- KTTA N/A
- Revenue This Year
- MGIC $11.11
- KTTA N/A
- Revenue Next Year
- MGIC $6.83
- KTTA N/A
- P/E Ratio
- MGIC $25.76
- KTTA N/A
- Revenue Growth
- MGIC 11.98
- KTTA N/A
- 52 Week Low
- MGIC $10.42
- KTTA $0.65
- 52 Week High
- MGIC $22.00
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- MGIC 42.26
- KTTA 43.23
- Support Level
- MGIC $19.79
- KTTA $0.74
- Resistance Level
- MGIC $20.80
- KTTA $0.81
- Average True Range (ATR)
- MGIC 0.50
- KTTA 0.06
- MACD
- MGIC -0.03
- KTTA -0.01
- Stochastic Oscillator
- MGIC 31.46
- KTTA 9.32
About MGIC Magic Software Enterprises Ltd.
Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).